Five-year experience with implantable defibrillators in children.
Cardioverter-defibrillators were implanted in children aged 4 to 16 years over a 5-year period with no mortality and eventual clinically appropriate shocks in 6 of 11 patients. Both transvenous and epicardial implantable cardioverter-defibrillators were safe and effective in children resuscitated from sudden death or at high risk for sudden death.
Hamilton
R M
RM
Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario.
Dorian
P
P
Gow
R M
RM
Williams
W G
WG
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D017147:Defibrillators, Implantable; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D016019:Survival Analysis; D013610:Tachycardia / Q000628:therapy*; D016896:Treatment Outcome